Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;54(1):52-61.
doi: 10.1055/a-1376-2394. Epub 2021 Mar 8.

Endoscopic ultrasound-directed transgastric ERCP (EDGE): a systematic review describing the outcomes, adverse events, and knowledge gaps

Affiliations

Endoscopic ultrasound-directed transgastric ERCP (EDGE): a systematic review describing the outcomes, adverse events, and knowledge gaps

Shaurya Prakash et al. Endoscopy. 2022 Jan.

Abstract

BACKGROUND : Endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography (EDGE) has emerged as a viable completely endoscopic method for performing pancreaticobiliary interventions in patients with Roux-en-Y gastric bypass anatomy. The aims of this systematic review were: (1) to describe the indications, outcomes, and complications of EDGE; and (2) to identify deficiencies in our knowledge of important technical approaches and clinical outcomes. METHODS : A systematic review was conducted via comprehensive searches of Medline, Scopus, CINAHL, and Cochrane to identify studies focusing on EDGE outcomes. Simple descriptive statistics were derived from case series only. Case reports were only included to qualitatively describe additional indications, techniques, and adverse events. RESULTS : The initial search identified 2143 abstracts. Nine case series and eight case reports were included. In the nine case series, 169 patients underwent EDGE. The technical success rate was 99 % (168 /169) for gastrogastrostomy/jejunogastrostomy creation and 98 % (166 /169) for subsequent ERCP. Minor adverse events specifically related to EDGE occurred in 18 % (31/169) and included intraprocedural stent migration/malposition (n = 27) and abdominal pain (n = 4). Moderate adverse events specific to EDGE occurred in 5 % (9/169): including bleeding (2 %), persistent fistula (1 %), and perforation (1 %). Severe adverse events occurred in one patient with a perforation requiring surgery. Deficiency in reporting on the clinical significance of adverse events was identified. CONCLUSION : Based on limited observational data, in expert hands, EDGE has a high rate of technical success and an acceptable rate of adverse events. As a novel procedure, many knowledge gaps need to be addressed to inform the design of meaningful comparative studies and guide informed consent.

PubMed Disclaimer

Conflict of interest statement

B.J. Elmunzer is a consultant for Takeda Pharmaceuticals. E.M. Forster receives research support from BMS, Janssen, and Takeda, and is a consultant for AbbVie. G.A. Cote receives research support from Kangen Pharmaceuticals and Boston Scientific Corporation; he is a consultant for Boston Scientific Corporation, Olympus Corporation of the Americas, and Abbvie. The remaining authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Schematic showing the use of endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography (EDGE) to facilitate endoscopic retrograde cholangiopancreatography in a patient with Roux-en-Y anatomy. In this example, a lumen-apposing metal stent (LAMS) is used to create a gastro-gastrostomy and access the excluded stomach.
Fig. 2
Fig. 2
PRISMA diagram of the abstract and full-text review. EDGE, endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography; EA-ERCP, enteroscopy-assisted endoscopic retrograde cholangiopancreatography; LA-ERCP, laparoscopy-assisted ERCP; LAMS, lumen-apposing metal stent.

Comment in

References

    1. Moran RA, Ngamruengphong S, Sanaei O et al.. EUS-directed transgastric access to the excluded stomach to facilitate pancreaticobiliary interventions in patients with Roux-en-Y gastric bypass anatomy. Endosc Ultrasound 2019; 8: 139–145 - PMC - PubMed
    1. Forster E, Elmunzer BJ. Endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y gastric bypass. Am J Gastroenterol 2020; 115: 155–157 - PubMed
    1. Wang TJ, Ryou M. Evolving techniques for endoscopic retrograde cholangiopancreatography in gastric bypass patients. Curr Opin Gastroenterol 2018; 34: 444–450 - PubMed
    1. Ngamruengphong S, Nieto J, Kunda R et al.. Endoscopic ultrasound-guided creation of a transgastric fistula for the management of hepatobiliary disease in patients with Roux-en-Y gastric bypass. Endoscopy 2017; 49: 549–552 - PubMed
    1. Tyberg A, Nieto J, Salgado S et al.. Endoscopic ultrasound (EUS)-directed transgastric endoscopic retrograde cholangiopancreatography or EUS: mid-term analysis of an emerging procedure. Clin Endosc 2017; 50: 185–190 - PMC - PubMed

Publication types

MeSH terms